ABBV vs ASML
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ABBV · AbbVie$291.31 ▲ 1.07%
ASML · ASML Holding$1,424.75 ▲ 5.02%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ABBV +36.3%
- ASML +37.8%
Head to head
| Metric | ABBV | ASML |
|---|---|---|
| Price | $291.31 | $1,424.75 |
| Change today | ▲ 1.07% | ▲ 5.02% |
| Market cap | $514.92B | $547.25B |
| Return, 3 months | +17.5% | -17.8% |
| Return, year to date | +30.5% | +33.8% |
| Return, 1 year | +36.1% | +40.8% |
| P/E (TTM) | 50.1 | 36.3 |
| P/B | -112.3 | 22.1 |
| P/E percentile vs own 5y | 77th | 56th |
| Dividend yield | 2.34% | 0.62% |
| Revenue growth (YoY, latest qtr) | +10.3% | +55.2% |
| Net profit growth (YoY) | +2,144.7% | +133.5% |
| Gross margin | 73.7% | 54.3% |
| Operating margin | 36.0% | 38.6% |
| Net margin | 15.7% | 34.1% |
| Return on equity | – | 65.6% |
| Analyst target vs. price | +7.4% | +77.8% |
| Analyst buy share | 87% | 100% |
| RSI (14) | 60 | 35 |
| 30-day volatility | 23.8% | 51.7% |
| Max drawdown, 1 year | -15.7% | -31.7% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ASML is the largest of the group by market value.
- ASML has returned the most over the past year.
- ASML carries the lowest trailing P/E.
- ABBV pays the highest dividend yield.
- ASML is growing revenue fastest.
- ASML keeps the most profit per dollar of sales.
- ABBV has been the calmest stock over the last 30 days.